Hip Joint Injection
- PMID: 32644449
- Bookshelf ID: NBK559023
Hip Joint Injection
Excerpt
Hip pain is a common clinical complaint and a source of disability with an incidence of 12 to 15 percent among all adults over the age of 60 years. Radiographic hip osteoarthritis affects 27% of adults above the age of 45 years. A lifetime risk of 25% is seen in those who are older than 85 years of age and with a 10% lifetime risk for eventual total hip replacement. Osteoarthritis of the hip involves a progressive loss of articular cartilage. Subchondral cysts, osteophyte formation, and synovial inflammation can subsequently develop. Therapeutic hip joint injection with corticosteroids, hyaluronic acid, and plasma-rich platelets have formed the cornerstone of non-surgical management of hip pain.
The important aspects of a fluoroscopic guided hip joint injection include:
Minimize patient discomfort
Maintain patient safety
Maintain proper needle technique in accessing the intraarticular joint space
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Christmas C, Crespo CJ, Franckowiak SC, Bathon JM, Bartlett SJ, Andersen RE. How common is hip pain among older adults? Results from the Third National Health and Nutrition Examination Survey. J Fam Pract. 2002 Apr;51(4):345-8. - PubMed
-
- Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, Fang F, Schwartz TA, Nelson AE, Abbate LM, Callahan LF, Kalsbeek WD, Hochberg MC. Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol. 2009 Apr;36(4):809-15. - PMC - PubMed
-
- Culliford DJ, Maskell J, Kiran A, Judge A, Javaid MK, Cooper C, Arden NK. The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage. 2012 Jun;20(6):519-24. - PubMed
Publication types
LinkOut - more resources
Full Text Sources